Send2Press Newswire
Fri, 03 Feb 2012 19:11:42 GMT
Patented Plug-in Release Expected to Rocket Share Values
NEW YORK, N.Y., Jan. 31, 2012 (SEND2PRESS NEWSWIRE) -- As part of Masterseek's ongoing effort to increase the size of their database while improving functionality they have recently created and patented a unique search technology for their website (US Patent application 61592495). The new plug-in is expected to debut before the end of February, 2012.
Masterseek is the world's largest B2B search engine, with over 100 million businesses in its database. The site offers users the ability to do a focused search for businesses in their area and abroad without the "clutter" associated with consumer-based search engines like Google. It also provides businesses opportunity to increase web presence with a searchable profile easily found online by their potential clients or potential business partners.
The search browser plug-in performs searches based on geo-location and allows direct search functions through three popular browsers. Upon entering a keyword into the internet browser application the search process is initiated. The server receives the request and searches Masterseek's database for only relevant businesses given the criteria specified, returning the geo-specific results. Creators of the plug-in claim this search technology is more comprehensive, including businesses which other searches may discount while ensuring a higher level of relevance, eliminating those businesses more accurately which do not fit the proper criteria of the search.
"The technology is a step above pretty much any search engine's ability to properly sort results we've ran across, and we are always researching what other search engines are doing right and what they are doing wrong," said Rasmus Refer, CEO of Masterseek.com. "This is going to make searching for the right business on the user side a whole lot easier and much more accurate. Imagine if you are a business on one of the other popular search engines; how many business partners or potential clients are missing your site just because the search function is not as accurate as ours?"
Refer adds: "That we are continuing to make these kinds of drastic improvements to Masterseek.com, even though we are already the top B2B search engine, really shows our commitment to users and to the businesses that make a profile within our database. I hope we will continue to see more success because of innovations like this-and I hope the businesses that join our database become more successful as well."
About Masterseek Corporation:
Masterseek is a B2B search engine and the largest business database in the world, with over 101 million businesses listed from all around the world. Businesses can create a profile on Masterseek.com free of charge and have full control over their business page. The web address is www.masterseek.com .
NEWS SOURCE: Masterseek Corporation
This story was issued by Send2Press® Newswire on behalf of the news source and is Copyright © 2012 Neotrope® News Network - all rights reserved.
TAGS: Masterseek Corporation, Patent and Trademark, Send2Press.
Tue, 31 Jan 2012 16:35:59 GMT
SecuGen Obtains Permanent Injunction Against Suprema Distributors and OEM Partners in Patent Infringement Lawsuit
SANTA CLARA, Calif., Dec. 6, 2011 (SEND2PRESS NEWSWIRE) -- SecuGen Corporation, a world leading provider of fingerprint sensor technology in Silicon Valley, announced that it has obtained a permanent injunction against Suprema distributors and OEM partners that are additional defendants in SecuGen's ongoing patent infringement lawsuit against Suprema.
The United States District Court for the Northern District of California has ordered that Suprema distributors and OEM partners RBH Access Technologies, Inc. and RBH USA, Inc. are permanently prohibited from importing, offering for sale, distributing or selling within the United States products that incorporate non-licensed Suprema fingerprint sensors, including RBH-BFR-200-S, RBH-BFR-200-M, RBH-BFR-300-S, RBH-BFR-300-M, and RBH-BFR-USB.
SecuGen has alleged that optical fingerprint sensors made by Suprema Inc. and incorporated into biometric security products by Suprema and its distributors and OEM partners willfully infringe SecuGen's patent, U.S. Patent No. 6,324,020, issued in 2001. This patent covers core imaging technology that SecuGen has developed to produce optical fingerprint sensors that are used in biometric security applications, such as door locks, time & attendance, access control, and labor tracking systems.
Suprema's products accused of infringing SecuGen's patent cover a wide range of optical fingerprint biometric Access Control, Time Attendance, Embedded Module, and PC Solution products, which include but are not limited to: BioEntry Plus, BioLite Net, BioLite Solo, BioMini, BioMini Plus, BioStation, BioStation T2, D-Station, SFM 2020-OP, SFM3020-OP, SFM3030-OD, SFM3040-OC, SFM3520-OP, SFM3530-OD, SFM4020-OP, SFR300-S, SFU300, and SFU500.
Since 1998, SecuGen has made considerable investment in research and development for its core technologies and to develop, maintain, and protect its valuable patents throughout the world including the U.S., Canada, Europe, and Asia. SecuGen's patents have been tested through previous patent litigation with two separate companies, have been submitted for reexamination before the United States Patent and Trademark Office, and have survived and been strengthened by numerous invalidation attempts.
About SecuGen:
SecuGen Corporation (www.secugen.com) is the world's leading provider of advanced, optical fingerprint recognition technology, products, tools and platforms for physical and information security. SecuGen designs and develops FBI-certified fingerprint readers and OEM components, developer kits and software, including NIST/MINEX-compliant algorithms. Known for high quality, ruggedness, and performance in a wide variety of applications and environmental conditions, SecuGen products are used by world-leading financial, medical, government, educational and corporate institutions and are sold through a partner network of over 200 original equipment manufacturers, independent software vendors and system integrators around the world.
SecuGen® is a registered trademark of SecuGen Corp. in the United States and other countries.
NEWS SOURCE: SecuGen Corporation
This story was issued by Send2Press® Newswire on behalf of the news source and is Copyright © 2011 Neotrope® News Network - all rights reserved.
TAGS: SecuGen Corporation, Patent and Trademark, Send2Press.
Tue, 06 Dec 2011 08:59:24 GMT
SecuGen Sues Suprema Distributors and OEM Partners for Patent Infringement
SANTA CLARA, Calif., Oct. 17, 2011 (SEND2PRESS NEWSWIRE) -- SecuGen Corporation, a world leading provider of fingerprint sensor technology in the Silicon Valley, announced today that it has added RBH Access Technologies, Inc., RBH USA, Inc., and Apiary, Inc. as defendants in its ongoing patent infringement lawsuit against Suprema. These additional defendants are distributors and OEM manufacturers that make, use, and sell products containing the Suprema sensors that have been accused of infringing SecuGen's patent, U.S. Patent No. 6,324,020.
The patent-in-suit was issued in 2001 and covers core imaging technology for optical fingerprint sensors that are used in biometric security applications, such as door locks, time & attendance, access control, and labor tracking systems.
Products produced by Suprema and its OEM partners that are accused of infringing SecuGen's patent include but are not limited to: BioEntry Plus, BioLite Net, BioLite Solo, BioMini, BioMini Plus, BioStation, BioStation T2, D-Station, SFM 2020-OP, SFM3020-OP, SFM3030-OD, SFM3040-OC, SFM3520-OP, SFM3530-OD, SFM4020-OP, SFR300-S, SFU300, SFU500, RBH-BFR-200-S, RBH-BFR-200-M, RBH-BFR-300-S, RBH-BFR-300-M, and RBH-BFR-USB.
Since 1998, SecuGen has made considerable investment in research and development for its core technologies and to develop, maintain, and protect its valuable patents throughout the world including the U.S., Canada, Europe, and Asia. SecuGen's patents have been tested through previous patent litigation with two separate companies, have been submitted for reexamination before the United States Patent and Trademark Office, and have survived and been strengthened by numerous invalidation attempts.
About SecuGen:
SecuGen Corporation (www.secugen.com) is the world's leading provider of advanced, optical fingerprint recognition technology, products, tools and platforms for physical and information security. SecuGen designs and develops FBI-certified fingerprint readers and OEM components, developer kits and software, including NIST/MINEX-compliant algorithms. Known for high quality, ruggedness, and performance in a wide variety of applications and environmental conditions, SecuGen products are used by world-leading financial, medical, government, educational and corporate institutions and are sold through a partner network of over 200 original equipment manufacturers, independent software vendors and system integrators around the world.
SecuGen® is a registered trademark of SecuGen Corp. in the United States and other countries.
NEWS SOURCE: SecuGen Corporation
This story was issued by Send2Press® Newswire on behalf of the news source and is Copyright © 2011 Neotrope® News Network - all rights reserved.
TAGS: SecuGen Corporation, Patent and Trademark, Send2Press.
Mon, 17 Oct 2011 08:59:30 GMT
Leader v. Facebook Federal Appeals Fight Begins
COLUMBUS, Ohio, July 26, 2011 (SEND2PRESS NEWSWIRE) -- Yesterday Leader Technologies filed its opening brief in its patent infringement fight against Facebook at the Court of Appeals for the Federal Circuit in Washington, D.C. Leader is represented by King & Spalding LLP and lead counsels Paul Andre, Lisa Kobialka, Daryl Joseffer and Adam Conrad. The nine-day jury trial in Delaware ended on July 27, 2010 with a split verdict.
At trial, Facebook was judged to be "literally infringing" Leader's U.S. Patent No. 7,139,761 on 11 of 11 claims, and the jury also found that the invention was not obvious over the published prior art. Put simply, this means that the software engine driving Facebook is Leader's invention.
However, the jury found the patent invalid on the theory that Leader had engaged in premature commercial activity more than one year before the patent application was filed. According to Leader, while much evidence was presented on both sides regarding infringement and prior art, Facebook presented no evidence to support its allegations of early commercial activity. Facebook had the "heavy burden" to present "clear and convincing evidence" to prove its allegation that Leader disclosed the invention prematurely. The clear and convincing standard was recently reaffirmed by the Supreme Court in Microsoft v. i4i.
Leader argues that an attempt to invalidate computer software inventions requires hard evidence like source code, engineering documents, developer testimony, drawings, schematics and expert witnesses to prove early commercial activity. Facebook provided no such proof. Leader cites cases where invalidity verdicts were overturned when infringers failed to provide hard evidence.
The law on Facebook's burden of proof requires Facebook to prove that each and every element of Leader's invention was present in the alleged 2002 offers. Leader states that various products were sold in 2002, but none of them included the invention "because it did not exist at that time."
Leader argues that Facebook had all versions of Leader's source code and engineering documents, and that Facebook would surely have used the code had it actually discovered any evidence of Leader's alleged early commercial activity. CEO Mike McKibben said, "Facebook didn't produce any of our source code because the programmer notations in our code prove they are wrong."
Leader argues that "if requiring clear and convincing evidence of invalidity is to be more than an empty semantic exercise, it must mean that the jury's verdict here cannot stand."
Facebook's response is due according to the court Rules.
About Leader:
Leader Technologies Incorporated is located in Columbus, Ohio and may be reached thru John Needham at 614-890-1986 or online at www.leader.com .
- RSS news feed for Leader: http://send2pressnewswire.com/author/leader-technologies-incorporated/feed .
NEWS SOURCE: Leader Technologies Incorporated
This story was issued by Send2Press® Newswire on behalf of the news source and is Copyright © 2011 Neotrope® News Network - all rights reserved.
TAGS: Leader Technologies Incorporated, Patent and Trademark, Send2Press.
Tue, 26 Jul 2011 22:34:05 GMT
SecuGen Files Counter Complaint Against Suprema for Fraud, Breach of Contract, and Negligent Misrepresentation
SANTA CLARA, Calif., July 26, 2011 (SEND2PRESS NEWSWIRE) -- SecuGen Corporation, a world leading provider of optical fingerprint technology based in Silicon Valley, announced that it has filed counterclaims against Korean biometric company Suprema Inc. for fraud, breach of contract, and negligent misrepresentation. These claims were filed along with an answer to a complaint by Suprema in the U.S. District Court of the Northern District of California regarding SecuGen's termination of an OEM Agreement between the two companies.
The OEM Agreement from which these claims arise was entered into between the companies in 2009, whereby Suprema agreed to purchase SecuGen's fingerprint sensors, design them into its products, and promote the bundled product, as opposed to using infringing sensors.
However, within two years of signing the OEM Agreement, SecuGen terminated the agreement after giving repeated notice that Suprema failed to perform its obligations. The counter complaint alleges that Suprema had no intention of complying with the OEM Agreement from the beginning and that it had made fraudulent representations to induce SecuGen to enter into the agreement so that it could infringe on SecuGen's valuable IP rights. It further alleges that Suprema made other false and misleading representations to delay SecuGen's termination of the agreement and to gain additional time to design around SecuGen's patents.
SecuGen is seeking a court order to void the OEM Agreement as well as damages for fraud, breach of contract, and negligent misrepresentation.
SecuGen owns key patents that are required to manufacture compact and cost effective fingerprint sensors with high image quality. SecuGen's patents have been tested through patent litigation with two separate companies, have been submitted for reexamination before the United States Patent and Trademark Office, and have survived and been strengthened by numerous invalidation attempts. The strength of SecuGen's intellectual property is well known in the industry, including by Suprema who has been aware of the SecuGen patents for many years.
Even Suprema has stated in its original complaint, "As Suprema prepared for and underwent its initial public offering in July 2008, Suprema sought to avoid negative publicity associated with potential litigation risks due to SecuGen's claim by entering into an agreement with SecuGen...."
In addition to the dispute about the OEM Agreement, SecuGen has previously filed a complaint against Suprema in the same court for patent infringement. Suprema's products accused of infringing SecuGen's patent cover a vast range of optical fingerprint biometric Access Control, Time Attendance, Embedded Module, and PC Solution products, which include but are not limited to: BioEntry Plus, BioLite Net, BioLite Solo, BioMini, BioMini Plus, BioStation, BioStation T2, D-Station, SFM 2020-OP, SFM3020-OP, SFM3030-OD, SFM3040-OC, SFM3520-OP, SFM3530-OD, SFM4020-OP, SFU300, and SFU500.
About SecuGen:
SecuGen Corporation (www.secugen.com) is the world's leading provider of advanced, optical fingerprint recognition technology, products, tools and platforms for physical and information security. Headquartered in Santa Clara, California, SecuGen designs and develops FBI-certified fingerprint readers and OEM components, developer kits and software, including NIST/MINEX-compliant algorithms. Known for high quality, ruggedness, and performance in a wide variety of applications and environmental conditions, SecuGen products are used by world-leading financial, medical, government, educational and corporate institutions and are sold through a partner network of over 200 original equipment manufacturers, independent software vendors and system integrators around the world.
SecuGen Corporation, 2065 Martin Avenue Suite 108, Santa Clara, Calif. 95050, USA; Tel 408.727.7787.
- RSS news feed for SecuGen Corporation: http://send2pressnewswire.com/author/secugen-corporation/feed .
NEWS SOURCE: SecuGen Corporation
This story was issued by Send2Press® Newswire on behalf of the news source and is Copyright © 2011 Neotrope® News Network - all rights reserved.
TAGS: SecuGen Corporation, Legal and Law, Send2Press.
Tue, 26 Jul 2011 20:04:03 GMT
BetterThanDiamond.com Files Patent Re-Exam Request for Charles and Colvard's U.S. Patent
SEATTLE, Wash., July 26, 2011 (SEND2PRESS NEWSWIRE) -- BetterThanDiamond, Inc. (www.BetterThanDiamond.com), a privately held U.S. corporation, today announced it has filed a patent re-examination request with the U.S. Patent & Trademark Office regarding Charles & Colvard's (NASDAQ: CTHR) patent for manufacturing "Silicon Carbide Gemstones." The patent in contention has allowed Charles & Colvard, Ltd. to enjoy a monopoly position and bill itself as the "sole manufacturer" of Silicon Carbide, or Moissanite, gemstones. Moissanite is a lab-grown semi-conductor material with optical properties, such as fire and brilliance, which are superior to gem-quality diamond.
The patent is U.S. 5,723,391 and covers the manufacture of Silicon Carbide, or Moissanite, gemstones. The filing requests the USPTO review and consider the validity of this U.S. patent in light of three "prior art" publications provided to the USPTO by BetterThanDiamond. The three publications span three decades - one each from the 60's, 70's and 80's. Per 35 USC 103, a patent may not be granted when the subject matter as a whole would have been obvious at the time the invention was made in light of prior art. None of the three provided publications, or "prior art," had been disclosed to the patent examiner or USPTO at the time the current patent was granted.
"The patent system is designed to promote and protect innovation," said Less P. Wright, President, BetterThanDiamond.com. "This patent however, was thrown out in Korea on the basis of 'lack of innovation' - and we couldn't agree more. Our filing, however, goes beyond opinions regarding innovation or lack thereof, and provides three prior art publications that make obvious to those skilled in the art how to manufacture silicon carbide, or Moissanite, gemstones. We do not believe Charles & Colvard's patent would have been granted had the USPTO been aware of these previous publications. Thus, we are filing today to allow the USPTO to review the patent's validity in light of these new disclosures."
BetterThanDiamond has had several breakthroughs related to the manufacture and improved optical properties of Silicon Carbide or Moissanite, for its "Mira Moissanite" program. However, they have been prevented from combining all of their breakthroughs into a single product offering due to the current patent held by Charles & Colvard. These breakthroughs include patent applications in progress for a new Hearts and Arrows round cut, and the ability to atomically enhance the colorlessness of all Moissanite, including the Moissanite sold by Charles & Colvard. For example - the Mira enhancement process is able to take a typical 1.5ct round from Charles & Colvard, which grades K or "Faint Color" on the diamond color scale, and permanently transform it to H color, or true near colorless. H color grade is a whiter diamond color much more in demand by jewelry consumers than K, or "faint color," and BetterThanDiamond intends to greatly expand its production of Mira Moissanite once the patent issue is resolved.
The patent re-exam process is expected to take between 3 to 6 months before the USPTO issues a decision.
"We anticipate that our current filing will result in the invalidation of the current patent held by Charles & Colvard. With a successful outcome and our manufacturing no longer restricted, we expect to further surprise jewelry lovers globally with the true beauty of our Mira Moissanite. At that point, we can utilize all of our technology and show Mira's 'Beauty Beyond Diamond™' properties to full effect," said Mr. Wright.
About BetterThanDiamond:
With its background in solid state chemistry and materials science, BetterThanDiamond.com is focused on the research, development and delivery of the world's most stunning lab grown gems. A 17 year old private company with customers in over 25 countries, BetterThanDiamond supplies lab grown jewelry products to jewelers and consumers globally.
For more information, visit: http://BetterThanDiamond.com .
All trademarks acknowledged.
NEWS SOURCE: BetterThanDiamond, Inc.
This story was issued by Send2Press® Newswire on behalf of the news source and is Copyright © 2011 Neotrope® News Network - all rights reserved.
TAGS: BetterThanDiamond, Inc., Patent and Trademark, Send2Press.
Tue, 26 Jul 2011 16:56:01 GMT
SecuGen Corporation Files Lawsuit Against Suprema for Patent Infringement
SANTA CLARA, Calif., July 18, 2011 (SEND2PRESS NEWSWIRE) -- SecuGen Corporation, a world leading provider of optical fingerprint technology, announced that it has filed a lawsuit in the U.S. District Court of the Northern District of California against Korean biometric company Suprema Inc. for patent infringement.
The complaint is related to U.S. Patent No. 6,324,020 issued in 2001 and owned by SecuGen, which covers invaluable technology for acquiring high quality fingerprint images that are crucial to the performance and accuracy of optical fingerprint sensors in biometric security applications.
Suprema's products accused of infringing SecuGen's patent cover a vast range of optical fingerprint biometric Access Control, Time Attendance, Embedded Module, and PC Solution products, which include but are not limited to: BioEntry Plus, BioLite Net, BioLite Solo, BioMini, BioMini Plus, BioStation, BioStation T2, D-Station, SFM 2020-OP, SFM3020-OP, SFM3030-OD, SFM3040-OC, SFM3520-OP, SFM3530-OD, SFM4020-OP, SFU300, and SFU500.
Since 1998, SecuGen has made considerable investments to conduct true research and development on its core technologies and to develop, maintain, and protect its valuable patents throughout the world in North America, Europe, and Asia.
"We have always respected the proprietary rights of others and expect our competitors to do the same," stated Won Lee, President and CEO of SecuGen. "We will vigorously defend our intellectual property rights including our long-standing patents."
In addition to seeking a declaration by the Court that Suprema's importation, use, sale or offer to sell fingerprint biometric products in the United States infringe SecuGen's patent, SecuGen is seeking preliminary and permanent injunctions against Suprema's future infringement of the patent and recovery of treble damages for knowing and willful infringement by Suprema.
About SecuGen:
SecuGen Corporation (www.secugen.com) is the world's leading provider of advanced, optical fingerprint recognition technology, products, tools and platforms for physical and information security. SecuGen designs and develops FBI-certified fingerprint readers and OEM components, developer kits and software, including NIST/MINEX-compliant algorithms. Known for high quality, ruggedness, and performance in a wide variety of applications and environmental conditions, SecuGen products are used by world-leading financial, medical, government, educational and corporate institutions and are sold through a partner network of over 200 original equipment manufacturers, independent software vendors and system integrators around the world.
SecuGen Corporation, 2065 Martin Avenue Suite 108, Santa Clara, Calif. 95050, USA; Tel 408.727.7787.
- RSS news feed for SecuGen Corporation: http://send2pressnewswire.com/author/secugen-corporation/feed .
NEWS SOURCE: SecuGen Corporation
This story was issued by Send2Press® Newswire on behalf of the news source and is Copyright © 2011 Neotrope® News Network - all rights reserved.
TAGS: SecuGen Corporation, Patent and Trademark, Send2Press.
Mon, 18 Jul 2011 08:58:01 GMT
WebPAX Announces Approval of Key Patent for Web-Based Routing of Medical Images across Multiple Hospitals and within the Cloud
DURHAM, N.C., June 8, 2011 (SEND2PRESS NEWSWIRE) -- Heart Imaging Technologies, LLC (the "Company" and dba "WebPAX") is pleased to announce that the United States Patent and Trademark Office (USPTO) has granted the Company another key individual patent, further strengthening its patent portfolio relating to zero-footprint technologies necessary to view diagnostic-quality medical images in a standard Internet web browser. The new U.S. Patent Number 7,958,100 covers the use of web browser redirection routing technology to provide efficient and seamless web access to medical images that are stored in different geographic locations.
The Company holds three additional U.S. patents and five patent applications pending, all of which underlie the Company's WebPAX® Medical Image Management Systems, a commercialized and FDA-approved technology that enables viewing and analysis of diagnostic-quality medical images in a bare-bones web browser with full PACS capabilities and that seamlessly integrates into EMRs, EHRs and web-portals.
The parent application was filed in 2000. Before allowing the patent USPTO examiners considered thousands of related patents, journal articles, and other publications dating back to 1987, of which 114 were specifically cited. No prior art was found that described how web browser redirection could be used to manage medical images across different hospitals.
"When we filed this patent everyone was focused on using desktop applications for viewing medical images within a single hospital. We were the first to describe how to design a system that provides global access to a distributed database of medical images by leveraging the now-ubiquitous World Wide Web framework," said co-founder Robert M. Judd, Ph.D.
The cloud computing revolution is poised to have a major impact on the healthcare IT market, with the most profound disruptive influence in medical imaging, a $170 billion a year market. Despite the DICOM standard, the medical imaging industry is replete with technical fragmentation, inoperability dysfunction and sharing inefficiencies. Consequently, an estimated $30 billion in the U.S. is spent on unnecessary medical imaging, about $15 billion of which is due to redundant procedures that result from a physician's lack of access to prior imaging exams. The Company's WebPAX® technology allows the efficient sharing, viewing and analysis of medical images from any DICOM source (modality or PACS), eliminating the time and cost associated with redundant exams, avoiding excessive radiation exposure for patients and obviating the costs and inefficiencies of shuttling around and managing CDs.
"Customer demand from hospitals, imaging centers, physician practices, payors and ACOs, combined with the availability of Web 2.0 and cloud computing technologies, will make the days of traditional PACS, one-off viewers and extensive infrastructure associated with image management numbered," said Dr. Judd.
The electronic medical record is intended to serve as the sole integration point of all types of medical data in order to provide a cohesive and comprehensive view of the patient. However, despite the critical importance of medical images to the entire longitudinal medical record, integration of images into the EMR has proved elusive for a variety of technical, territorial, cost and work-flow considerations.
As a PACS-vendor neutral and web-based architecture, the WebPAX® platform complements and maximizes the utility of any existing PACS and EMR/EHR investments by providing zero-footprint access to all medical images and videos through a simple web-link (URL) within a third-party EMR/EHR system that automatically points to the images associated with the specific patient imaging procedure which can be viewed with diagnostic quality from any web-connected computer or device.
"Whether access to images are made available through the EMR, EHR, web portals, PACS-interface and/or cloud-based delivery models, the difficulty lies in providing immediate web-access to images stored in different hospitals or data centers as images accumulate," stated Dr. Judd. "Traditional approaches have required that images are copied from one hospital to another before they can be viewed, which is intrinsically slow, cumbersome and expensive. Our proprietary technology provides that functionality with a single mouse click and this method, which is covered by this newly issued patent, is the most efficient technical approach possible within the framework of World Wide Web technologies."
"This patent places the Company in a unique position and provides protection of our core technology as the scaling of medical images across enterprises and/or within the cloud continues to accelerate. This advancement is important because our patented technology eliminates the need to copy images from one hospital to another by automatically routing the physician's web browser to the hospital where the image is actually stored. As a result, physicians have immediate access to images located at different hospitals or data centers."
As medical imaging moves to the cloud, this patented technology also covers the ability to efficiently provide web browser access to medical images stored in multiple geographic locations, which has important implications for cloud-based and SaaS providers. "Using a single data center to store all images from all hospitals or imaging providers - within a network - is impractical due to the enormous size of medical images. WebPAX's patented technology enables cloud-based providers to utilize multiple, geographically-dispersed data centers while acting as a single information source from the physician's perspective. Our newly issued patent protects the use of web browser redirection in this context of seamless controlled web access routing to medical images stored in different geographic locations."
Founded in 2000 and headquartered near North Carolina's Research Triangle Park, WebPAX provides zero-footprint, web-based medical image management technology and services to health care systems, large hospitals and private clinics as well as drug and device companies sponsoring multi-center clinical trials. Worldwide, WebPAX® systems currently provide secure web browser access to over 500 million medical images.
For more information, visit: http://www.heartit.com .
NEWS SOURCE: Heart Imaging Technologies
This story was issued by Send2Press® Newswire on behalf of the news source and is Copyright © 2011 Neotrope® News Network - all rights reserved.
TAGS: Heart Imaging Technologies, Patent and Trademark, Send2Press.
Wed, 08 Jun 2011 09:59:12 GMT
U.S. Patent Awarded to Sample Digital for Innovative Online Media Workflow Technology
HOLLYWOOD, Calif., Feb. 1 (SEND2PRESS NEWSWIRE) -- Sample Digital Holdings LLC announces today that the United States Patent and Trademark Office has issued a patent for a system and method for media content collaboration throughout the media production process. The patent was issued as U.S. Patent No. 7,660,416 ("the '416 Patent").
"We believe this is an important moment for Sample Digital because the '416 Patent covers both current and future technology relating to the collaboration of media content throughout the entire pre- and post-production process," stated Patrick Macdonald King, CEO of Sample Digital.
"The patent is a culmination of extensive research, creative vision and real-world application of Sample's technology and allows studios, broadcast and cable companies to easily and effectively collaborate on all aspects workflow and production of media content. Sample Digital believes the '416 patent provides a competitive edge to Sample Digital and further marks Sample Digital as the leader in this field."
About Sample Digital Holdings LLC
Hollywood-based Sample Digital (www.sampledigital.com) delivers targeted workflow and media asset management applications and services to companies who produce, distribute and license audio-visual and rich media content.
Sample Digital's suite of applications, including dax|D3™, Digital Dailies® and iDailies®, optimize business process in content production and distribution management for such creative leaders as 20th Century Fox, CBS, Warner Bros., Showtime, Lifetime Television, Summit Entertainment, and Lionsgate. Our clients have found using Sample Digital's platform reduces production and distribution expenditures, improves time to market and minimizes risk - both creatively and financially.
Sample Digital's core platform, dax|D3, is a highly secure web-based environment where users can share ideas, information and content created throughout the production or campaign lifecycle, or as required for trafficking and distribution of final product. dax|D3 incorporates media production workflow and collaboration, transcoding, distribution and security services into one robust, extendible solution available via desktop, set top box and mobile applications such as dax|Mobile, an iPad application available in April 2011.
NEWS SOURCE: Sample Digital
This story was issued by Send2Press® Newswire on behalf of the news source and is Copyright © 2011 Neotrope® News Network - all rights reserved.
TAGS: Sample Digital, Patent and Trademark, Send2Press.
Tue, 01 Feb 2011 22:51:45 GMT
Authernative Granted U.S. Patent for Two-Credential Authentication Factor
REDWOOD CITY, Calif., Dec. 15 (SEND2PRESS NEWSWIRE) -- Authernative, Inc., the leading developer of innovative user authentication and identity management technologies, announced today that the United States Patent Office has granted the company a patent for a user authentication method.
The newly issued U.S. Patent No. 7,849,321, titled "Authentication method of random partial digitized path recognition with a challenge built into the path" adds to Authernative's array of authentication methods based on random partial pattern recognition algorithms. It advances the security of Authernative's pattern based one-time PIN technology to provide a "what user knows" two-credential authentication.
With Authernative's Passline® pattern-based one-time PIN solution, the user's credential is a secret pattern on a virtual grid of cells. During each login session, the digital content on the grid is randomized and the user is challenged to enter the content from the randomly specified set of positions of his pattern. The newly patented Crossline™ technology extends the above method by concealing the location of the challenge inside the grid as a second "what user knows" secret credential. The combination of two secret credentials on the grid having randomized content, used to generate a one-time response, surpasses the security of one-time PIN tokens.
Dr. Len Mizrah, President and CEO of Authernative said, "This technology fills a security gap that afflicts existing knowledge based authentication solutions, such as passwords or security questions, without the need to carry a token, a smart card, mobile device or any other authenticator, and without threat of credential compromise. Moreover, unlike a combination of a PIN and token, where the PIN is static and the token is displayed to anyone in its possession, Authernative's patented technology reliably veils both credentials."
The newly patented Crossline™ technology has a variety of applications. For example, the Crossline™ can be used by a field operative to securely access an online resource without having to carry a separate device, which could compromise the operative or access to the resource. Similarly, a consumer can use the Crossline™ at an Internet cafe to strongly authenticate himself without anything more than his theft-proof knowledge-based secret. While, an enterprise employee can use the Crossline™ to gain secure access to the network from anywhere in the world. Or a bank or healthcare provider can offer Crossline™ for security conscious users without added costs or inconvenience.
This user-centric authentication method provides a common user experience from all networked devices including computers, mobile devices, smart cards, set-top-boxes, Point-of-Sale, ATM, VoIP terminal or touch screen displays. It provides stronger security than hardware-based authenticators while preserving the cost-effective, electronic mass deployment and ease of use typical of passwords.
The technology is part of the AuthGuard® versatile authentication platform offering different methods and levels of authentication to meet a range of security and usability requirements. AuthGuard® provides one-factor, layered, and multi-factor authentication that is electronically mass deployable, has scalable security, high usability and low total cost of ownership. AuthGuard® patented authentication methods include enhanced password, pattern-based one-time PIN, out-of-band, and mobile client solutions. AuthGuard® is also integrated with the FIPS 140-2 certified Authernative® Cryptographic Module and utilizes a patented encryption key management system combined with a mutual authentication protocol.
Authernative's granted patent adds to the company's patent portfolio solidifying the company's ability to provide innovative, secure and cost-effective user authentication solutions. With the increase in advanced persistent threats, identity theft, cyber crime, and data breaches, enterprises, government agencies, online service providers, and consumers can benefit from AuthGuard® authentication product to secure online and mobile access to networks, cloud computing and SaaS.
About Authernative:
Authernative provides innovative software security solutions offering identity and access management capabilities including advanced authentication, secure remote and mobile access, and user credentialing. The company's products are used to assure authenticated access to devices, confidential data, protected resources, information sharing and transactions. They allow businesses and government agencies to lower the cost of providing, deploying and managing strong user authentication for enabling e-government, e-business and addressing corporate and regulatory compliance requirements. Authernative holds multiple US and foreign patents, GSA schedule, FIPS 140-2 certification and the 2009 Best Security Solution award from the Government Technology Research Alliance (GTRA) Council. http://www.authernative.com .
- News RSS feed for Authernative:
http://send2pressnewswire.com/topics/authernative-inc/feed .
NEWS SOURCE: Authernative, Inc.
This story was issued by Send2Press® Newswire on behalf of the news source and is Copyright © 2010 Neotrope® News Network - all rights reserved.
TAGS: Authernative, Inc., Patent and Trademark, Send2Press.
Wed, 15 Dec 2010 18:17:17 GMT
|
